EMPHYSEMA OR COPD
Clinical trials for EMPHYSEMA OR COPD explained in plain language.
Never miss a new study
Get alerted when new EMPHYSEMA OR COPD trials appear
Sign up with your email to follow new studies for EMPHYSEMA OR COPD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New valve treatment helps severe COPD patients breathe easier
Disease control CompletedThis study tracked 155 adults with severe emphysema or COPD who received Zephyr Valve treatment. The goal was to see if the valves improved lung function by at least 12% after one year. The registry collected safety and effectiveness data to support continued use of the device in…
Matched conditions: EMPHYSEMA OR COPD
Sponsor: Pulmonx Corporation • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New lung implant shows promise for emphysema sufferers
Disease control CompletedThis study tested a new implant designed to release trapped air in the lungs of people with severe emphysema or COPD. Up to 48 participants received up to two procedures to place the implants, then were followed for a year. The main goals were to check if the procedure is safe an…
Matched conditions: EMPHYSEMA OR COPD
Phase: NA • Sponsor: Apreo Health, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Could a cold virus drug prevent COPD Flare-Ups?
Disease control CompletedThis study tested an investigational drug called vapendavir in 52 adults with COPD (a chronic lung disease). The goal was to see if vapendavir could reduce lower respiratory symptoms like cough, wheezing, and shortness of breath after they were exposed to a common cold virus (rhi…
Matched conditions: EMPHYSEMA OR COPD
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Can aspirin and clopidogrel boost lung health in smokers?
Knowledge-focused CompletedThis study looked at whether taking two blood thinners (aspirin and clopidogrel) for two weeks can improve blood flow in the lungs of current and former smokers, both with and without COPD. Fifteen people participated in a crossover design where each person received both the acti…
Matched conditions: EMPHYSEMA OR COPD
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:09 UTC